First-line treatment for mild to moderate histoplasmosis.

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

First-line treatment for mild to moderate histoplasmosis.

Explanation:
Itraconazole is the preferred first-line treatment for mild to moderate histoplasmosis because it has strong activity against Histoplasma capsulatum and penetrates tissues well, making it effective for pulmonary and mild disseminated forms. It works by inhibiting the fungal enzyme 14-alpha-demethylase, which blocks ergosterol synthesis and disrupts the fungal cell membrane. The typical regimen starts with 200 mg three times daily for 3 days, then 200 mg twice daily, and is continued for at least 12 months with monitoring of response and liver function. Fluconazole is less potent against Histoplasma and is not preferred as initial therapy; other azoles like voriconazole or ketoconazole have inferior activity or safety concerns, and amphotericin B is reserved for severe disease.

Itraconazole is the preferred first-line treatment for mild to moderate histoplasmosis because it has strong activity against Histoplasma capsulatum and penetrates tissues well, making it effective for pulmonary and mild disseminated forms. It works by inhibiting the fungal enzyme 14-alpha-demethylase, which blocks ergosterol synthesis and disrupts the fungal cell membrane. The typical regimen starts with 200 mg three times daily for 3 days, then 200 mg twice daily, and is continued for at least 12 months with monitoring of response and liver function. Fluconazole is less potent against Histoplasma and is not preferred as initial therapy; other azoles like voriconazole or ketoconazole have inferior activity or safety concerns, and amphotericin B is reserved for severe disease.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy